BioCatalyst

31-valent pneumococcal conjugate vaccine, PCV20 — catalyst calendar

1 verified catalyst event(s) referencing 31-valent pneumococcal conjugate vaccine, PCV20, each linked to its official source. Verified as of 2026-10-31.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03 (month)
in 4mo
ESTIMATED
 READOUT
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prio
Phase 3 · Pneumococcal Vaccines
 PCVX Vaxcyte, Inc. 31-valent pneumococcal conjugate vaccine ClinicalTrials.gov ↗
✓ Source-checked 2026-10-31
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.